Literature DB >> 11769581

Systemic lupus erythematosus presenting earlier as retinal vaso-occlusion.

Y H Song1, C G Kim, S D Kim, Y Y Kim, J Y Choe.   

Abstract

Retinal vascular lesions are the most common ophthalmologic manifestation of systemic lupus erythematosus (SLE), occurring in 3% to 29% of cases, generally late in the disease. More rare is the severe vaso-occlusive disease, often termed "retinal vasculitis", which includes central retinal artery occlusion, multifocal arteriolar occlusions, extensive capillary nonperfusion and central venous occlusion. Patients with SLE and raised serum concentrations of anticardiolipin antibodies (ACA) have a higher risk of developing occlusive ocular vascular disease. We report a case in which retinal involvement was an earlier manifestation of SLE in a patient without ACA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11769581      PMCID: PMC4531720          DOI: 10.3904/kjim.2001.16.3.210

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  9 in total

1.  Retinal arterial occlusive disease in systemic lupus erythematosus.

Authors:  D Gold; L Feiner; P Henkind
Journal:  Arch Ophthalmol       Date:  1977-09

2.  The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.

Authors:  M Petri; M Rheinschmidt; Q Whiting-O'Keefe; D Hellmann; L Corash
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

Review 3.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

4.  Microangiopathy of the retinal arterioles.

Authors:  D D Pfaffenbach; R W Hollenhorst
Journal:  JAMA       Date:  1973-07-30       Impact factor: 56.272

5.  Ocular findings in systemic lupus erythematosus.

Authors:  D H Gold; D A Morris; P Henkind
Journal:  Br J Ophthalmol       Date:  1972-11       Impact factor: 4.638

6.  Occlusive retinal vascular disease in systemic lupus erythematosus.

Authors:  S Hall; H Buettner; H S Luthra
Journal:  J Rheumatol       Date:  1984-12       Impact factor: 4.666

Review 7.  The clotting defect in SLE.

Authors:  M A Byron
Journal:  Clin Rheum Dis       Date:  1982-04

8.  Severe retinal vaso-occlusive disease in systemic lupus erythematous.

Authors:  D A Jabs; S L Fine; M C Hochberg; S A Newman; G G Heiner; M B Stevens
Journal:  Arch Ophthalmol       Date:  1986-04

9.  SLE retinopathy: evaluation by fluorescein angiography.

Authors:  J G Lanham; T Barrie; E M Kohner; G R Hughes
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

  9 in total
  2 in total

1.  Severe ischemic retinopathy in a patient with systemic lupus erythematosus without antiphospholipid syndrome: A case report.

Authors:  El Asri Fouad; Momen Hanane; Belmalih Mounir; Zarrouk Rachid; Reda Karim; Oubaaz Abdelber
Journal:  Saudi J Ophthalmol       Date:  2014-09-22

2.  Case Report: Recurrent retinal vein occlusion as the first clinical manifestation of systemic lupus erythematosus in a male patient.

Authors:  Marwa Ben Brahim; Sondes Arfa; Fadia Boubaker; Jihen Chelly; Wafa Ammari; Sonia Hammami; Fatma Arbi; Olfa Berriche
Journal:  F1000Res       Date:  2021-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.